% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Rllen:821076,
author = {Röllen, Katrin and Granzin, Joachim and Panwalkar, Vineet
and Arinkin, Vladimir and Rani, Raj and Hartmann, Rudolf and
Krauss, Ulrich and Jaeger, Karl-Erich and Willbold, Dieter
and Batra-Safferling, Renu},
title = {{S}ignaling {S}tates of a {S}hort {B}lue-{L}ight
{P}hotoreceptor {P}rotein {P}p{SB}1-{LOV} {R}evealed from
{C}rystal {S}tructures and {S}olution {NMR} {S}pectroscopy},
journal = {Journal of molecular biology},
volume = {428},
number = {19},
issn = {0022-2836},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {FZJ-2016-06320},
pages = {3721 - 3736},
year = {2016},
abstract = {Light–Oxygen–Voltage (LOV) domains represent the
photo-responsive domains of various blue-light photoreceptor
proteins and are widely distributed in plants, algae, fungi,
and bacteria. Here, we report the dark-state crystal
structure of PpSB1-LOV, a slow-reverting short LOV protein
from Pseudomonas putida that is remarkably different from
our previously published “fully light-adapted” structure
[1]. A direct comparison of the two structures provides
insight into the light-activated signaling mechanism. Major
structural differences involve a ~11 Å movement of the C
terminus in helix Jα, ~4 Å movement of Hβ–Iβ loop,
disruption of hydrogen bonds in the dimer interface, and a
~29° rotation of chain-B relative to chain-A as compared to
the light-state dimer. Both crystal structures and solution
NMR data are suggestive of the key roles of a conserved
glutamine Q116 and the N-cap region consisting of
A′α–Aβ loop and the A′α helix in controlling the
light-activated conformational changes. The activation
mechanism proposed here for the PpSB1-LOV supports a rotary
switch mechanism and provides insights into the signal
propagation mechanism in naturally existing and artificial
LOV-based, two-component systems and regulators.},
cin = {ICS-6 / IMET},
ddc = {570},
cid = {I:(DE-Juel1)ICS-6-20110106 / I:(DE-Juel1)IMET-20090612},
pnm = {553 - Physical Basis of Diseases (POF3-553) / 581 -
Biotechnology (POF3-581)},
pid = {G:(DE-HGF)POF3-553 / G:(DE-HGF)POF3-581},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000384383400005},
pubmed = {pmid:27291287},
doi = {10.1016/j.jmb.2016.05.027},
url = {https://juser.fz-juelich.de/record/821076},
}